• About
    • Executive Team
    • Scientific Advisors
    • Board of Directors
  • Technology
  • News
  • Contact Us
LuxCath

LuxCath Appoints Terry Ransbury as Chief Technology Officer

by Mark Biagini | Oct 4, 2018 | In The Press, Press Release, Uncategorized

Company Also Announces Two Medtech Veteran Additions Rick Randall and John Fletcher to its Board of Directors   BOSTON – October 4, 2018 – LuxCath, LLC, a medical device company developing a novel cardiac catheter ablation technology, today announced that Terry...

Recent Posts

  • LuxCath Appoints Terry Ransbury as Chief Technology Officer
  • MassDevice.com: LuxCath eyes the atrial fibrillation market
  • Medtech Insight Pharma Intelligence: HRS 2018 Wrap-Up: LuxCath’s OmniView
  • EPLab Digest: Using Fluorescence and Optics to View Lesions During Cardiac Ablation: Interview with Dr. Vivek Reddy
  • LuxCath to Showcase Its Breakthrough OmniView Light-Guided Ablation Catheter at HRS 2018

Recent Comments

    Archives

    • October 2018
    • May 2018
    • April 2018
    • December 2015

    Categories

    • In The Press
    • Press Release
    • Uncategorized

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org
    LUXCATH LLC | AN ALLIED MINDS COMPANY | ALL RIGHTS RESERVED © 2018